{"task_id": "3181b9b0075cf489", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 111/464)", "text": "ally has\nclear CXR with cardiomegaly only\n98\nShock\n\n--- Page 120 ---\nRelated Topics\nAnaphylaxis (p. 372)\nMyocardial Infarction (p. 26)\nSepsis (p. 99)\nTamponade (p. 32)\nMANAGEMENT\nACUTE\nABC, O2, cardiac and oximetry monitoring,\nIV fluid resuscitation (1 5 L), ICU consult, consider\nintubation/mechanical ventilation, inotropes/vaso\npressors (Norepinephrine 1 30 mg/min IV. Vasopres\nsin 0.01 0.04 U/min IV. Epinephrine 1 20 mg/min IV.\nEphedrine 5 25 mg IV q5 10min until blood pressure\nstable. Phenylephrine 20 200 mg/min IV. Dobutamine\nMANAGEMENT (CONT\u2019D)\n2.5 15 mg/kg/min IV. Milrinone 0.375 0.75 mg/kg/\nmin IV. Dopamine start 1 4 mg/kg/min IV, titrate to\nmaximum 20 mg/kg/min. Midodrine 5 10 mg PO TID).\nCorrect\ncoagulopathy\n(transfuse\nPRBC,\nFFP,\ncryoprecipitate)\nTREAT UNDERLYING CAUSE\nTREATMENT ISSUES\nINOTROPES/VASOPRESSORS\n\u0004\nPHYSIOLOGY\na1 = peripheral vasoconstriction\n= \" peripheral vascular resistance = treatment\nfor sepsis; b1 = inotropic and chronotropic\neffect = \" cardiac output = treatment for heart\nfailure; b2 = peripheral vasodilation = counter a1\neffect\nAgent\nMechanism of action\nSpecial note\nNorepinephrine\na1 mainly, b1 ! \" PVR, \" CO\nFirst line for septic shock\nVasopressin\nV1, V2 ! dilates renal, pulmonary,\ncerebral, coronary arteries and\nconstricts others\nSecond line for sepsis;\nAE: Gut ischemia, skin necrosis\nEpinephrine\nb1, b2, a1 ! \" CO, \" PVR\nSalvage for sepsis, first line for\nanaphylaxis;\nAE: ischemia\nPhenylephrine\na1 ! \" PVR\nSepsis, counteract spinal/epidural\nanesthesia\nEphedrine\nb1, b2, a1 ! \" CO, \" PVR\nBolus therapy pending CVC\nplacement for continuous\nvasopressor therapy\nDobutamine\nb1, b2 ! \" CO, # PVR\nFirst line for cardiogenic shock\nMilrinone\nPhosphodiesterase inhibitor !\n\" CO, # PVR\nFirst line for cardiogenic shock with\npulmonary HTN\nDopamine 1 2 mg/kg/min\nDA ! dilates renal, mesenteric,\ncerebral arteries and airways\n\" renal perfusion/GFR\n(controversial)\nDopamine 5 10 mg/kg/min\nDA, b1 ! \" CO\nHF/sepsis;\nAE: tachycardia\nDopamine >10 mg/kg/min\na1 ! \" PVR\nSepsis/HF;\nAE: tachycardia\nMidodrine\na1 ! \" PVR\nSepsis; oral\nwhere AE=adverse effects, CO=cardiac output, CVC=central venous catheter, DA=dopamine, HF=heart\nfailure, HTN=hypertension, PVR=peripheral vascular resistance\nSepsis and Septic Shock\nNEJM 2006 355:16\nSurviving Sepsis Campaign Guidelines Crit\nCare Med 2008 36:1\nPATHOPHYSIOLOGY\nDEFINITIONS\n\u0004\nSIRS\n\u00072 of temperature >38.38C [>100.98F] or\n<368C [<96.88F], heart rate >90 beats min,\nrespiratory rate >20 or PaCO2 <32 mmHg, WBC\n>12\u0002109/L or <4 \u0002109/L or >10% bands\nPATHOPHYSIOLOGY (CONT\u2019D)\n\u0004\nSEPSIS\nSIRS plus documented or suspected infection\n\u0004\nSEVERE\nSEPSIS\nsepsis associated hypoperfusion\nleading to lactic acidosis, oliguria, or acute altera\ntion of mental status (i.e. sepsis plus organ\ndysfunction)\nSepsis and Septic Shock\n99", "text_length": 2785, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 111/464)", "type": "chunk", "chunk_index": 110, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.396826", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.397528", "status": "complete", "chunks_added": 2}